Arlt Christian C

Show results for

Proteomics (3)
Unknown (2)
Models (1)

Organisms

Alphavirus (2)
Anemia (2)
Betaherpesvirinae (2)
Brassica oleracea var. oleracea (2)
Cowpox virus (2)
Coxsackievirus (2)
Cytomegalovirus (2)
Dengue virus (2)
EFO:0001352 (2)
Filoviridae (2)
Hepatitis B virus (2)
Human alphaherpesvirus 1 (2)
Human betaherpesvirus 5 (2)
Human immunodeficiency virus (2)
Human immunodeficiency virus 1 (2)
Human immunodeficiency virus 2 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus (2)
Japanese encephalitis virus group (2)
Lyssavirus rabies (2)
Monkeypox virus (2)
Orthopoxvirus (2)
Orthopoxvirus vaccinia (2)
Rattus (2)
Ruditapes decussatus (2)
Staphylococcus aureus (2)
Tick-borne encephalitis virus (2)
Viruses (2)
West Nile virus (2)

Repository

pride (2)
Cell Collective (1)
MassIVE (1)

Tissue

Saliva (1)

Disease

Severe acute respiratory syndrome (1)

Technology Type

Mass Spectrometry (2)
Chemical cross-linking coupled with mass spectrometry proteomics (1)
Shotgun proteomics (1)

Instrument Platform

Orbitrap Fusion (1)

Publication Date

2020 (3)

Release Date

2022 (1)
2012 (1)

Lab affiliation

Institute for Biochemistry and Biotechnology, Martin Luther University Halle-Wittenberg (1)
Martin-Luther University Halle-Wittenberg Institute of Pharmacy Department of Pharmaceutical Chemistry & Bioanalytics Charles Tanford Protein Center (1)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Reconstitution of mammalian Cleavage Factor II

Cleavage factor II (CF II) is a poorly characterized component of the multi-protein complex catalyzing 3' cleavage and polyadenylation of mammalian mRNA precursors. We have reconstituted CF II as a heterodimer of hPcf11 and hClp1. The heterodimer is active in partially reconstituted cleavage reactio...

ORGANISM(S): Homo sapiens (Human)

2020-05-26 | PXD010177 | Pride

Mammalian Cell Cycle

BACKGROUND: In breast cancer, overexpression of the transmembrane tyrosine kinase ERBB2 is an adverse prognostic marker, and occurs in almost 30% of the patients. For therapeutic intervention, ERBB2 is targeted by monoclonal antibody trastuzumab in adjuvant settings; however, de novo resistance to t...

1607 | Cell Collective

MS analysis of SARS-CoV2 proteins from patient samples

We developed a simple, MS-based method to specifically detect SARS-CoV-2 proteins from gargle solution samples of COVID-19 patients. Our protocol consists of an acetone precipitation and tryptic digestion of proteins contained within the gargle solution, followed by a targeted MS analysis. Our metho...

ORGANISM(S): Homo sapiens (Human)

2020-06-26 | PXD019423 | Pride

Covid-19 Nucleoprotein Sars-cov-2 Mass spectrometry

MS analysis of SARS-CoV2 proteins from patient samples

ORGANISM(S): Homo Sapiens (ncbitaxon:9606)

2020-07-16 | MSV000085761 | MassIVE

Hepatitis B virus-induced lipid alterations contribute to natural killer T cell-dependent protective immunity.

Not available

S-EPMC3478098 | biostudies-literature

Lung emphysema and impaired macrophage elastase clearance in mucolipin 3 deficient mice.